Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dorothee M Gescher"'
Autor:
Linda M. Bonnekoh, Stephanie Seidenbecher, Katrin Knigge, Anne-Kathrin Hünecke, Coraline D. Metzger, Claus Tempelmann, Martin Kanowski, Jörn Kaufmann, Gabriela Meyer-Lotz, Konstantin Schlaaff, Henrik Dobrowolny, Leonardo Tozzi, Dorothee M. Gescher, Johann Steiner, Clemens Kirschbaum, Thomas Frodl
Publikováno v:
The world journal of biological psychiatry 24(1), 34-45 (2023). doi:10.1080/15622975.2022.2058084
Objectives Major Depression (MDD) and anxiety disorders are stress-related disorders that share pathophysiological mechanisms. There is evidence for alterations of glutamate-glutamine, N-acetylaspartate (NAA) and GABA in the anterior cingulate cortex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15e4f234e5001d919fe37bf9b8b49f9f
Autor:
Fienne-Elisa Beckmann, Stephanie Seidenbecher, Coraline D Metzger, Dorothee M Gescher, Angela Carballedo, Leonardo Tozzi, Veronica O'Keane, Thomas Frodl
Publikováno v:
Psychiatry research. Neuroimaging. 321
Several studies in major depressive disorder (MDD) have found inflammation, especially C-reactive protein (CRP), to be consistently associated with MDD and network dysfunction. The aim was to investigate whether CRP is linked to a distinct set of res
Autor:
Holger Jahn, Klaus Wiedemann, Michael Kellner, Thomas J. Raedler, Birgit Goedeken, Dorothee M. Gescher
Publikováno v:
Depression and anxiety. 23(3)
Progestational hormones may have anxiolytic properties. CCK-4 (cholecystokinin tetrapeptide) can be used pharmacologically to induce panic attacks both in normal controls and patients suffering from panic disorder. In this study we compared the effec
Autor:
Dorothee M. Gescher, Holger Jahn, M. Kellner, Klaus Wiedemann, B. Goedecken, Thomas J. Raedler
Publikováno v:
ResearcherID
Autor:
Thomas J. Raedler, Birgit Goedeken, Michael Kellner, Dorothee M. Gescher, Klaus Wiedemann, Holger Jahn
Publikováno v:
Cancer chemotherapy and pharmacology. 52(6)
Clinical observations suggest that prolonged treatment with megestrol can lead to Cushing-like symptoms, while withdrawal of prolonged treatment with megestrol may result in adrenal insufficiency. However, only little is known about the acute effects
Autor:
Dorothee M. Gescher, K. Widemann, B. Goedecken, Michael Kellner, Thomas J. Raedler, Holger Jahn
Publikováno v:
European Neuropsychopharmacology. 13:S354